Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2021-03-30
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
27,869$23.93$666,905
2021-03-30
Purchase
Edgewise Therapeutics, Inc.EWTXORBIMED ADVISORS LLC
Director, 10% owner
359,375$16.00$5,750,000
2021-03-30
Purchase
Ikena Oncology, Inc.IKNAORBIMED ADVISORS LLC
Director
423,400$16.00$6,774,400
2021-03-29
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
75,555$23.31$1,761,187
2021-03-26
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
27,816$23.88$664,246
2021-03-25
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
51,523$24.70$1,272,618
2021-03-24
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
32,959$24.80$817,383
2021-03-23
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
3,992$24.32$97,085
2021-03-22
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
7,673$26.47$203,104
2021-03-19
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
21,275$26.47$563,149
2021-03-18
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
6,059$28.03$169,833
2021-03-17
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
18,790$28.43$534,199
2021-03-16
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
41,353$27.72$1,146,305
2021-03-15
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
89,210$29.14$2,599,579
2021-03-12
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
90,521$30.29$2,741,881
2021-03-11
Sale
Oric Pharmaceuticals, Inc.ORICORBIMED ADVISORS LLC
Director
58,551$33.04$1,934,525
2021-03-01
Sale
SpringWorks Therapeutics, Inc.SWTXORBIMED ADVISORS LLC
10% owner
1,220,000$83.19$101,491,800
2021-02-17
Purchase
Decibel Therapeutics, Inc.DBTXORBIMED ADVISORS LLC
Director, 10% owner
1,666,666$18.00$29,999,988
2021-02-17
Purchase
Corvus Pharmaceuticals, Inc.CRVSORBIMED ADVISORS LLC
Director, 10% owner
1,285,714$3.50$4,499,999
2021-02-09
Purchase
Terns Pharmaceuticals, Inc.TERNORBIMED ADVISORS LLC
Director, 10% owner
475,000$17.00$8,075,000
2021-01-07
Sale
CTI BIOPHARMA CORPCTICORBIMED ADVISORS LLC
10% owner
2,000,000$3.50$7,000,000
2020-12-28
Sale
ALPINE IMMUNE SCIENCES, INC.ALPNORBIMED ADVISORS LLC
Director, 10% owner
600,000$14.25$8,550,000
2020-12-08
Purchase
Silverback Therapeutics, Inc.SBTXORBIMED ADVISORS LLC
Director, 10% owner
1,190,477$21.00$25,000,017
2020-12-08
Sale
Aerpio Pharmaceuticals, Inc.ARPOORBIMED ADVISORS LLC
10% owner
21,400$1.96$41,944
2020-12-02
Purchase
Kinnate Biopharma Inc.KNTEORBIMED ADVISORS LLC
750,000$20.00$15,000,000
2020-11-02
Purchase
Galecto, Inc.GLTOORBIMED ADVISORS LLC
Director, 10% owner
733,333$15.00$10,999,995
2020-10-02
Purchase
Arcutis Biotherapeutics, Inc.ARQTORBIMED ADVISORS LLC
Director, 10% owner
496,000$25.00$12,400,000
2020-10-01
Purchase
LogicBio Therapeutics, Inc.LOGCORBIMED ADVISORS LLC
Director, 10% owner
1,481,482$6.00$8,888,892
2020-09-25
Purchase
PMV Pharmaceuticals, Inc.PMVPORBIMED ADVISORS LLC
Director, 10% owner
950,000$18.00$17,100,000
2020-09-25
Purchase
GRAYBUG VISION, INC.GRAYORBIMED ADVISORS LLC
10% owner
562,500$16.00$9,000,000
2020-09-25
Purchase
Prelude Therapeutics IncPRLDORBIMED ADVISORS LLC
Director, 10% owner
1,236,800$19.00$23,499,200
2020-09-21
Sale
89bio, Inc.ETNBORBIMED ADVISORS LLC
Director, 10% owner
275,000$28.00$7,700,000
2020-08-18
Sale
Inspire Medical Systems, Inc.INSPORBIMED ADVISORS LLC
Director
43,543$108.54$4,726,157
2020-08-17
Sale
Inspire Medical Systems, Inc.INSPORBIMED ADVISORS LLC
Director
94,900$107.49$10,200,801
2020-08-14
Sale
Inspire Medical Systems, Inc.INSPORBIMED ADVISORS LLC
Director
20,257$109.03$2,208,620
2020-08-13
Sale
Inspire Medical Systems, Inc.INSPORBIMED ADVISORS LLC
Director
29,251$109.93$3,215,562

1 2 3 4 5 6 7 8 9 10 11 Next >

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*